Sun Pharma may incur revenue loss from ransomware attack on March 2
Business Standard|March 28, 2023
India's largest drugmaker by market share Sun Pharmaceutical Industries (Sun Pharma) has admitted that its operations and revenues will be impacted by a cyberattack on its information technology (IT) assets that occurred on March 2.
SOHINI DAS
Sun Pharma may incur revenue loss from ransomware attack on March 2

The company said it has 'proactively' isolated its network and initiated a recovery process.

"As a result of these measures, the company's business operations have been impacted. Consequently, revenues are expected to be reduced in some of our businesses," Sun Pharma said in a regulatory filing late on Sunday night.

In a regulatory filing on Monday, Sun Pharma Advanced Research Company also said it may incur certain expenses in connection with the incident and the process of remediation.

"We are unable to determine the cost of remediation and other potential adverse impacts of the incident at this stage," the company stated.

Denne historien er fra March 28, 2023-utgaven av Business Standard.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

Denne historien er fra March 28, 2023-utgaven av Business Standard.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

FLERE HISTORIER FRA BUSINESS STANDARDSe alt
Sitharaman tables Manipur Budget with total expenditure of ₹35K cr
Business Standard

Sitharaman tables Manipur Budget with total expenditure of ₹35K cr

Finance Minister Nirmala Sitharaman on Monday tabled the Budget for financial year 2025-26 (FY26) for the strife-ridden state of Manipur with a total expenditure of ₹35,104 crore, up 7.5 per cent from the revised estimates of FY25.

time-read
1 min  |
March 11, 2025
India Needs to Innovate & Reduce Debt to Become Developed by 2047
Business Standard

India Needs to Innovate & Reduce Debt to Become Developed by 2047

India's gross domestic product (GDP) growth accelerated to 6.2 percent in the third quarter of FY25, up from 5.6 percent in the previous quarter.

time-read
1 min  |
March 11, 2025
Rupee Sees Worst Fall in 2 Weeks, Closing at 87.34 Against the Dollar
Business Standard

Rupee Sees Worst Fall in 2 Weeks, Closing at 87.34 Against the Dollar

The rupee fell the most in two weeks, weakening by 0.52 percent against the dollar on Monday due to strong demand for dollars in the non-deliverable forward (NDF) market.

time-read
1 min  |
March 11, 2025
Business Standard

EU Investors Eye Fresh Investments in Indian Equities: Macquarie

Investors from the European Union (EU) nations are looking to make fresh investments in domestic equities by cutting their underweight position, according to financial giant Macquarie.

time-read
1 min  |
March 11, 2025
Simplilearn Plans to Relaunch Fresher Upskilling Vertical
Business Standard

Simplilearn Plans to Relaunch Fresher Upskilling Vertical

Edtech Firm to Restart Study Abroad Programme as Well

time-read
2 mins  |
March 11, 2025
Experts brainstorm on new possibilities in India's power sector by 2047 and Global Trends in Energy Transition @GRIDCON 2025
Business Standard

Experts brainstorm on new possibilities in India's power sector by 2047 and Global Trends in Energy Transition @GRIDCON 2025

The theme of POWERGRID led GRIDCON 2025, a premier global event in the power transmission industry Innovations in Grid Resilience: Strategies for enhancing reliability Sustainability and Adaptability of Power Transmission System

time-read
4 mins  |
March 11, 2025
Ukraine overtakes India as top arms importer: Sipri
Business Standard

Ukraine overtakes India as top arms importer: Sipri

India was world's biggest importer of arms in 2019-23

time-read
2 mins  |
March 11, 2025
Business Standard

IndusInd Bank CEO search looms as shares drop 3.86%

Following the Reserve Bank of India's (RBI's) approval for only a one-year extension to IndusInd Bank's Managing Director (MD) and Chief Executive Officer (CEO) Sumant Kathpalia, instead of the three-year tenor requested by the bank's board, brokerages expect the bank to initiate the process of selecting a new CEO.

time-read
2 mins  |
March 11, 2025
Business Standard

India's obesity crisis

Reorienting food policies can address the problem

time-read
2 mins  |
March 11, 2025
Business Standard

Sun Pharma to expand oncology portfolio with Checkpoint buy

\"This acquisition further bolsters our innovative portfolio in onco-dermatology,\" Sun Pharma's Chairman and MD Dilip Shanghvi said.

time-read
1 min  |
March 11, 2025